Citation

Pfefferkorn J., Guzman-Perez A., Litchfield J., Aiello R., Treadway J., Pettersen J., Minich M., Filipski K., Jones C., Tu M., Aspnes G., Risley H., Bian J., Stevens B., Bourassa P., D’Aquila T., Baker L., Barucci N., Robertson A., Bourbonais F., Derksen D., MacDougall M., Cabrera O., Chen J., Lapworth A., Landro J., Zavadoski W., Atkinson K., Haddish-Berhane N., Tan B., Yao L., Kosa R., Varma M., Feng B., Duignan D., El-Kattan A., Murdande S., Liu S., Ammirati M., Knafels J., DaSilva-Jardine P., Sweet L., Liras S., Rolph T.: Discovery of (<i>S</i>)-6-(3-Cyclopentyl-2-(4-(trifluoromethyl)-1<i>H</i>-imidazol-1-yl)propanamido)nicotinic Acid as a Hepatoselective Glucokinase Activator Clinical Candidate for Treating Type 2 Diabetes Mellitus. Journal of Medicinal Chemistry, Volume 55 (3), 2012

Authors

Jeffrey A. Pfefferkorn, Angel Guzman-Perez, John Litchfield, Robert Aiello, Judith L. Treadway, John Pettersen, Martha L. Minich, Kevin J. Filipski, Christopher S. Jones, Meihua Tu, Gary Aspnes, Hud Risley, Jianwei Bian, Benjamin D. Stevens, Patricia Bourassa, Theresa D’Aquila, Levenia Baker, Nicole Barucci, Alan S. Robertson, Francis Bourbonais, David R. Derksen, Margit MacDougall, Over Cabrera, Jing Chen, Amanda Lee Lapworth, James A. Landro, William J. Zavadoski, Karen Atkinson, Nahor Haddish-Berhane, Beijing Tan, Lili Yao, Rachel E. Kosa, Manthena V. Varma, Bo Feng, David B. Duignan, Ayman El-Kattan, Sharad Murdande, Shenping Liu, Mark Ammirati, John Knafels, Paul DaSilva-Jardine, Laurel Sweet, Spiros Liras, Timothy P. Rolph

Journal

Journal of Medicinal Chemistry

Year

2012

DOI

10.1021/jm2014887

Machine-readable

REST APIRDF